# ANIX (Anixa Biosciences, Inc.) - SEC EDGAR Financial Statements

> Anixa Biosciences, Inc. reported $15.07M in total assets and a net loss of $10.38M through October 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ANIX
- Markdown: https://convexityos.com/fundamentals/ANIX.md
- SEC CIK: 0000715446
- Reporting currency: USD
- Latest filing period: July 31, 2026
- Last synced: Nov 20, 2026, 05:49 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000715446&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Oct 31, 2025 |
| Operating Income | FY 2025 | -$10.98M | Operating profit |
| Net Income | FY 2025 | -$10.38M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.30 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Jul 31, 2026 | $13.86M | Total debt: $174K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | $210K | $210K | -- | $512K | -- | $250K | $1.11M | $362K | $300K |
| Research & Development | $5.07M | $6.40M | $4.77M | $6.70M | $6.19M | $4.38M | $5.47M | $6.81M | $1.60M | $1.56M |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | $5.66M | $6.91M | $4.41M | $2.71M |
| **Operating Income** | -$11.70M | -$13.83M | -$11.01M | -$13.88M | -$13.14M | -$9.98M | -$11.89M | -$14.29M | -$6.08M | -$4.51M |
| **EBITDA** | -- | -- | -- | -- | -- | -$9.94M | -$11.42M | -$14.27M | -$6.03M | -$4.48M |
| Interest Income | $673K | $1.13M | $1.08M | $104K | $2.0K | $34K | $71K | $46K | $19K | $13K |
| Interest Expense | -- | -- | -- | -- | -- | -- | -- | -- | $500K | $520K |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -$11.82M | -$14.24M | -$5.01M | -$5.02M |
| **Net Income** | -$10.93M | -$12.55M | -$9.81M | -$13.60M | -$12.95M | -$10.02M | -$11.65M | -$14.00M | -$5.01M | -$5.02M |
| Basic EPS | -$0.34 | -$0.39 | -$0.32 | $0.45 | -$0.45 | -$0.45 | -$0.59 | -$0.79 | -$0.58 | -$0.57 |
| **Diluted EPS** | -$0.34 | -$0.39 | -$0.32 | $0.45 | -$0.45 | -$0.45 | -$0.59 | -$0.79 | -$0.58 | -$0.57 |
| Basic Shares Outstanding | 32.5K | 31.9K | 31.0K | 30.4K | 28.6M | 22.2M | 19.8M | 17.6M | 12.2M | 8.7M |
| Diluted Shares Outstanding | 32.5K | 31.9K | 31.0K | 30.4K | 28.6M | 22.2M | 19.8M | 17.6M | 12.2M | 8.7M |

### Income Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.33M | $1.26M | $1.10M | $1.14M | $1.05M | $1.32M | $1.55M | $1.48M |
| **Operating Income** | -$2.74M | -$2.65M | -$2.72M | -$2.88M | -$2.44M | -$3.00M | -$3.39M | -$3.16M |
| Interest Income | $112K | $111K | $131K | $154K | $156K | $190K | $173K | $250K |
| **Net Income** | -$2.61M | -$2.52M | -$2.56M | -$2.69M | -$2.26M | -$2.79M | -$3.18M | -$2.88M |
| Basic EPS | -$0.08 | -$0.07 | -$0.08 | -- | -$0.07 | -$0.09 | -$0.10 | -- |
| **Diluted EPS** | -$0.08 | -$0.07 | -$0.08 | -- | -$0.07 | -$0.09 | -$0.10 | -- |
| Basic Shares Outstanding | 34.2M | 33.6M | 33.2M | -- | 32.5M | 32.2M | 32.2M | -- |
| Diluted Shares Outstanding | 34.2M | 33.6M | 33.2M | -- | 32.5M | 32.2M | 32.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.24M | $1.27M | $915K | $12.36M | $29.13M | $6.42M | $3.49M | $3.06M | $3.34M | $2.49M |
| Short-Term Investments | $13.93M | $18.65M | $22.93M | $17.33M | $6.60M | $2.64M | $2.35M | $2.00M | $3.50M | $750K |
| **Cash & Short-Term Investments** | $15.17M | $19.92M | $23.84M | $29.69M | $35.73M | $9.06M | $5.84M | $5.06M | $6.84M | $3.24M |
| Accounts Receivable, Net | -- | $173K | $270K | $46K | -- | $2.2K | $67K | $307K | -- | -- |
| **Total Current Assets** | $15.89M | $21.36M | $25.36M | $30.20M | $36.00M | $9.37M | $6.09M | $5.54M | $7.01M | $3.40M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | $201K | $73K | $53K | $157K |
| **Total Non-Current Assets** | $193K | $229K | $166K | $212K | $254K | $84K | $201K | $910K | $1.80M | $2.23M |
| **Total Assets** | $16.08M | $21.59M | $25.52M | $30.41M | $36.26M | $9.45M | $6.29M | $6.45M | $8.81M | $5.63M |
| Accounts Payable | $165K | $525K | $206K | $265K | $136K | $232K | $586K | $582K | $480K | $373K |
| **Total Current Liabilities** | $1.97M | $2.50M | $2.03M | $2.04M | $1.27M | $1.19M | $1.48M | $1.27M | $889K | $469K |
| **Total Non-Current Liabilities** | $163K | $203K | $123K | $175K | $220K | $0 | $0 | $0 | $0 | $4.17M |
| **Total Liabilities** | $2.13M | $2.70M | $2.15M | $2.21M | $1.49M | $1.19M | $1.48M | $1.27M | $889K | $4.64M |
| **Total Debt (incl. Leases)** | $204K | $232K | $175K | $221K | $259K | $55K | -- | -- | -- | -- |
| Common Stock | $330K | $322K | $311K | $309K | $301K | $242K | $203K | $189K | $166K | $88K |
| Retained Earnings | -$251.7M | -$240.8M | -$228.2M | -$218.4M | -$204.8M | -$191.8M | -$181.8M | -$170.2M | -$156.2M | -$151.2M |
| **Total Stockholders' Equity** | $15.16M | $20.00M | $24.34M | $29.05M | $35.44M | $8.76M | $5.24M | $5.43M | $7.92M | $987K |
| Total Equity | $13.95M | $18.89M | $23.37M | $28.20M | $34.77M | $8.26M | $4.81M | $5.18M | $7.92M | $987K |

### Balance Sheet (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.40M | $1.48M | $1.55M | $1.24M | $1.50M | $1.91M | $1.05M | $1.27M |
| Short-Term Investments | $12.47M | $12.21M | $12.65M | $13.93M | $14.53M | $13.69M | $16.20M | $18.65M |
| **Cash & Short-Term Investments** | $13.86M | $13.69M | $14.20M | $15.17M | $16.03M | $15.60M | $17.25M | $19.92M |
| Accounts Receivable, Net | -- | $56K | -- | -- | -- | -- | -- | $173K |
| **Total Current Assets** | $14.91M | $14.69M | $15.05M | $15.89M | $17.45M | $16.77M | $18.69M | $21.36M |
| **Total Non-Current Assets** | $163K | $173K | $183K | $193K | $202K | $211K | $220K | $229K |
| **Total Assets** | $15.07M | $14.87M | $15.23M | $16.08M | $17.65M | $16.98M | $18.91M | $21.59M |
| Accounts Payable | $282K | $252K | $148K | $165K | $276K | $284K | $600K | $525K |
| **Total Current Liabilities** | $1.75M | $1.50M | $1.24M | $1.97M | $2.07M | $1.89M | $2.00M | $2.50M |
| **Total Non-Current Liabilities** | $128K | $140K | $151K | $163K | $174K | $184K | $194K | $203K |
| **Total Liabilities** | $1.87M | $1.64M | $1.39M | $2.13M | $2.24M | $2.07M | $2.19M | $2.70M |
| **Total Debt (incl. Leases)** | $174K | $184K | $193K | $204K | $213K | $221K | $230K | $232K |
| Common Stock | $346K | $339K | $335K | $330K | $328K | $322K | $322K | $322K |
| Retained Earnings | -$259.4M | -$256.8M | -$254.2M | -$251.7M | -$249.0M | -$246.7M | -$243.9M | -$240.8M |
| **Total Stockholders' Equity** | $14.47M | $14.47M | $15.08M | $15.16M | $16.59M | $16.07M | $17.85M | $20.00M |
| Total Equity | $13.20M | $13.22M | $13.85M | $13.95M | $15.41M | $14.91M | $16.71M | $18.89M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$11.03M | -$12.70M | -$9.93M | -$13.77M | -$13.13M | -$10.09M | -$11.82M | -$14.24M | -$5.01M | -$5.02M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | $38K | $466K | $18K | $43K | $33K |
| Stock-Based Compensation | $3.68M | $4.42M | $4.42M | $6.00M | $7.50M | $3.92M | -$5.71M | -$8.90M | -$1.68M | -- |
| Change in Receivables | $173K | $97K | -$224K | -$29K | -- | $64K | $272K | -$259K | -- | -- |
| Change in Payables | -$360K | $319K | -$59K | $129K | -$96K | -$353K | $3.8K | $102K | $107K | -$1.5K |
| **Operating Cash Flow** | -$7.17M | -$7.33M | -$6.21M | -$6.49M | -$4.94M | -$6.18M | -$4.74M | -$4.27M | -$3.80M | -$3.38M |
| Capital Expenditure | -- | -- | -- | -- | -- | -$16K | -$175K | -$38K | -$30K | -$147K |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -$6.19M | -$4.92M | -$4.31M | -$3.83M | -$3.53M |
| **Investing Cash Flow** | $4.87M | $4.28M | -$5.60M | -$10.73M | -$3.92M | -$306K | -$525K | $1.46M | -$2.74M | $1.50M |
| Common Stock Issued | $2.38M | $2.96M | -- | -- | $10.83M | $9.27M | $5.53M | $2.47M | $3.46M | -- |
| Share Repurchases | -- | -$6.0K | -- | -- | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $2.28M | $3.42M | $366K | $452K | $31.57M | $9.41M | $5.70M | $2.53M | $7.38M | -$2.7K |
| **Net Change in Cash** | -$27K | $356K | -$11.45M | -$16.77M | $22.71M | $2.93M | $436K | -$283K | $851K | -$1.88M |

### Cash Flow Statement (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.62M | -$2.54M | -$2.58M | -$2.72M | -$2.28M | -$2.81M | -$3.21M | -$2.91M |
| Stock-Based Compensation | $637K | $637K | $768K | $859K | $829K | $962K | $1.03M | $980K |
| Change in Receivables | -- | -- | -- | $0 | $0 | $0 | $173K | $237K |
| Change in Payables | $30K | $104K | -$17K | -$111K | -$8.0K | -$316K | $75K | $223K |
| **Operating Cash Flow** | -$1.77M | -$1.74M | -$2.61M | -$1.25M | -$1.51M | -$1.50M | -$2.90M | -$927K |
| **Investing Cash Flow** | -$245K | $422K | $1.23M | $654K | -$833K | $2.34M | $2.70M | $867K |
| Common Stock Issued | -- | -- | -- | $454K | $1.93M | $14K | -$17K | -$29K |
| **Financing Cash Flow** | $1.94M | $1.25M | $1.69M | $350K | $1.93M | $18K | -$17K | $106K |
| **Net Change in Cash** | -$79K | -$70K | $303K | -$251K | -$415K | $857K | -$218K | $46K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -6586.2% | -5243.3% | -- | -2565.6% | -- | -4756.0% | -1284.4% | -1676.0% | -1503.0% |
| **Net Profit Margin** | -- | -5978.1% | -4671.9% | -- | -2530.1% | -- | -4658.8% | -1258.1% | -1381.8% | -1672.1% |
| Return on Equity (ROE) | -72.1% | -62.8% | -40.3% | -46.8% | -36.6% | -114.3% | -222.5% | -257.5% | -63.2% | -508.0% |
| Return on Assets (ROA) | -68.0% | -58.1% | -38.4% | -44.7% | -35.7% | -106.0% | -185.1% | -217.0% | -56.8% | -89.1% |
| Current Ratio | 8.08x | 8.54x | 12.50x | 14.83x | 28.35x | 7.88x | 4.11x | 4.38x | 7.89x | 7.25x |
| Quick Ratio | 7.71x | 8.04x | 11.89x | 14.60x | 28.13x | 7.62x | 3.99x | 4.24x | 7.69x | 6.91x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | 0.0% | -- | -- | -- | -- | -77.5% | +206.9% | +20.8% | -96.8% |
| EPS Growth (YoY) | -- | -- | -171.1% | -- | -- | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -348.0% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -369.6% |
| 5Y Revenue / Share Growth | -- | +52014.3% | +10638.7% | -- | -47.8% | -- | -97.0% | +3092.2% | +470.1% | +471.0% |
| 10Y Revenue / Share Growth | -- | +1463.8% | +342700.0% | -- | +198.0% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -71.7% | -69.3% | -68.4% | -72.1% | -67.0% | -75.5% | -69.9% | -62.8% |
| Return on Assets (ROA) | -68.9% | -67.5% | -67.7% | -68.0% | -63.0% | -71.5% | -66.0% | -58.1% |
| Current Ratio | 8.54x | 9.79x | 12.18x | 8.08x | 8.45x | 8.89x | 9.35x | 8.54x |
| Quick Ratio | 7.94x | 9.16x | 11.49x | 7.71x | 7.76x | 8.27x | 8.63x | 8.04x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
